- Category
-
- Cancer / Oncology 4
- Cardiovascular 1
- Central nervous system 1
- Dental 1
- Dermatology 1
- Ear nose and throat 0
- Gastrointestinal 1
- Genetic disorders 1
- Genitourinary 1
- Gynecology 1
- Hematology 1
- Hospital care 1
- Immunology 2
- Infectious diseases 4
- Metabolic & endocrinology 1
- Musculoskeletal 1
- Obstetrics 0
- Orphan Diseases 1
- Ophthalmology 1
- Pediatrics 1
- Psychiatry 1
- Public health 0
- Rehabilitation medicine 0
- Respiratory 2
- Sensory organ 0
- Sexual health 0
Therapy reports
-
Global Coronavirus Partnering 2015-2022October 2022$3,995.00
The Global Coronavirus Partnering 2015-2022 report provides comprehensive understanding and unprecedented access to the coronavirus partnering agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Gynecology Partnering 2010-2022: Deal trends, players and financialsDecember 2022$3,995.00
The Global Gynecology Partnering 2010-2022: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the gynecology partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Autoimmune Partnering 2015-2022: Deal trends, players and financialsOctober 2022$3,995.00
The Global Autoimmune Partnering 2015-2022: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the autoimmune disease partnering deals and agreements entered into by the worlds leading healthcare companies
Learn More -
Global Cancer Diagnostics Partnering Terms and Agreements 2015-2022November 2022$3,995.00
The Global Cancer Diagnostics Partnering Terms and Agreements 2015-2022 report provides comprehensive understanding and unprecedented access to the cancer diagnostics partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Antibiotics Partnering Terms and Agreements 2010 to 2022November 2022$3,995.00
The Global Antibiotics Partnering Terms and Agreements 2010 to 2022 report provides comprehensive understanding and unprecedented access to the antibiotic partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Orphan Diseases Partnering 2010-2022: Deal trends, players and financialsNovember 2022$3,995.00
The Global Orphan Diseases Partnering 2010-2022: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the orphan diseases partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Genetic Disorders Partnering 2015-2022: Deal trends, players and financialsOctober 2022$3,995.00
Global Genetic Disorders Partnering 2015-2022: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the genetic disorders partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Hospital Care Partnering 2015-2022: Deal trends, players and financialsDecember 2022$3,995.00
Global Hospital Care Partnering 2015-2022: Deal trends, players and financials provides comprehensive understanding and unprecedented access to the hospital care partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Ophthalmics Partnering 2014-2022: Deal trends, players and financialsNovember 2022$3,995.00
The Global Ophthalmics Partnering 2014-2022: Deal trends, players and financials report provides comprehensive understanding and unprecedented access to the ophthalmics partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More -
Global Infectious Vaccines Partnering Terms and Agreements 2015 to 2022November 2022$3,995.00
The Global Infectious Vaccines Partnering Terms and Agreements 2015-2022 report provides comprehensive understanding and unprecedented access to the infectious vaccines partnering deals and agreements entered into by the worlds leading healthcare companies.
Learn More